Clinical trials
Phase 2 trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,350 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 8 |
| 2003 | 16 |
| 2004 | 24 |
| 2005 | 29 |
| 2006 | 40 |
| 2007 | 52 |
| 2008 | 53 |
| 2009 | 59 |
| 2010 | 67 |
| 2011 | 71 |
| 2012 | 67 |
| 2013 | 67 |
| 2014 | 57 |
| 2015 | 60 |
| 2016 | 62 |
| 2017 | 70 |
| 2018 | 61 |
| 2019 | 63 |
| 2020 | 67 |
| 2021 | 76 |
| 2022 | 62 |
| 2023 | 54 |
| 2024 | 70 |
| 2025 | 63 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 923 |
| Terminated | 212 |
| Active, not recruiting | 94 |
| Recruiting | 85 |
| Unknown status | 18 |
| Enrolling by invitation | 6 |
| Withdrawn | 6 |
| Not yet recruiting | 4 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 90 |
| Pfizer | 67 |
| AstraZeneca | 59 |
| Sanofi | 58 |
| Bayer | 47 |
| GlaxoSmithKline | 46 |
| Boehringer Ingelheim | 35 |
| Amgen | 33 |
| Hoffmann-La Roche | 33 |
| Eli Lilly and Company | 25 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 94 |
| Colitis, Ulcerative | 65 |
| Crohn Disease | 39 |
| Diabetes Mellitus, Type 2 | 38 |
| Asthma | 35 |
| Dermatitis, Atopic | 35 |
| Breast Neoplasms | 34 |
| Multiple Sclerosis | 29 |
| Heart Failure | 28 |
| Carcinoma, Non-Small-Cell Lung | 27 |
Trials
Showing 1 to 25 of 1,350. Each trial links to its page on Pharma Observatory.
1,250 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.